The Value of Prostate Specific Antigen and Transrectal Ultrasound Guided Biopsy in Detecting Prostatic Fossa Recurrences Following Radical Prostatectomy

Foster, Lionel S.; Jajodia, Prahalad; Fournier, George R.; Shinohara, Katsuto; Carroll, Peter R.; Narayan, Perinchery

doi:10.1016/s0022-5347(17)36287-0

Cited by 106 publications

(39 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This observation agrees with that of Foster et al 25 They also comment that the thickness of the anterior and posterior anastomotic soft tissues and the contour of the anterior bladder neck were not important factors in predicting biopsy results, in agreement to previous studies. 18,20 In their study, all perianastomotic masses were less echogenic than the surrounding retroanastomotic tissue and approximately isoechoic compared with the vesicourethral anastomosis and bladder neck.…”

Section: Introductionsupporting

confidence: 92%

“…Main possible complication is bleeding from the anastomotic site or haematuria but occurs rarely. 25,36,38 Transrectal ultrasonography enhances the detection of biopsy-positive disease if compared to DRE alone, in cases with biochemical recurrence after radical prostatectomy where there is no evidence of distal disease.…”

Section: Discussionmentioning

confidence: 99%

“…If initial Postradical prostatectomy TRUS-guided anastomotic biopsy T Anagnostou et al biopsy fails to establish local recurrence, one repeat biopsy would successfully diagnose local cancer in another 16-17% of cases. 25,34 Some authors 36 have also evaluated cases with normal PSA levels (o0.3 ng/ml) or lower 33 than 0.5 ng/ml, and reported that no local disease was discovered. These findings support the hypothesis that presence of local recurrence in PSA range below 0.5 ng/ml seems unlikely.…”

Section: Discussionmentioning

confidence: 99%

“…Foster et al 25 have found that local recurrence was not only confined to stage C disease but also to stage B disease. They also have not found any correlation between grade of recurrence and radical prostatectomy Gleason score, or PSA values before radical prostatectomy.…”

Section: Postradical Prostatectomy Trus-guided Anastomotic Biopsy T Amentioning

confidence: 99%

See 3 more Smart Citations

Postradical prostatectomy TRUS-guided anastomotic biopsy. Where do we stand today?

Anagnostou

Doumas

Remzi

et al. 2004

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

The issue of performing tissue sampling from the vesicourethral anastomotic area postradical prostatectomy (transrectal ultrasound-guided biopsy) after radical surgical treatment of local disease has failed, still remains controversial. We review a selection of articles that evaluate this procedure as well as newer diagnostic modalities and we discuss how this technique may have a position in our treatment dilemmas in cases with biochemical failure of undetermined origin.

show abstract

Section: Introductionsupporting

confidence: 92%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Postradical Prostatectomy Trus-guided Anastomotic Biopsy T Amentioning

confidence: 99%

See 2 more Smart Citations

Postradical prostatectomy TRUS-guided anastomotic biopsy. Where do we stand today?

Anagnostou

Doumas

Remzi

et al. 2004

Prostate Cancer Prostatic Dis

View full text Add to dashboard Cite

show abstract

“…Most studies have concentrated on men who had biochemical evidence of progression as the sole indication of failure (1). The few reports that evaluated local recurrence concentrated on clinical issues, including (1) the use of radiotherapy to treat local recurrence (2); (2) the need for several biopsies to document local recurrence (3)(4)(5); (3) the use of ultrasound, serum PSA, and digital rectal examination to detect local recurrence (3)(4)(5)(6)(7); and (4) the sites of local recurrence, including the anastomotic site (66%), bladder neck (16%), retrovesical space (13%), and unknown (5%) (3).…”

mentioning

confidence: 99%

Needle Biopsy of Recurrent Adenocarcinoma of the Prostate After Radical Prostatectomy

et al. 2000

View full text Add to dashboard Cite

The objective of this study was to evaluate needle biopsy of recurrent prostate cancer after radical prostatectomy. We evaluated 37 cases of recurrent prostate cancer after radical prostatectomy that were diagnosed by needle biopsy between March 1984 and July 1998. Fifteen were from consultations in which contributors were uncertain of the diagnosis, and 22 were from men who had come to The Johns Hopkins Hospital for treatment. The median interval from radical prostatectomy to biopsy showing recurrent tumor was 40 months. There was no correlation between the interval to recurrence and either pathologic features of the biopsy and radical prostatectomy or various clinical features. The mean extent of adenocarcinoma in the biopsies was 3.2 mm (range, 0.1 to 18 mm; median, 2 mm). The length of recurrent cancer on biopsy correlated with an abnormal rectal examination (P ‫؍‬ .001). The mean Gleason score for the recurrent tumors was 6.5, which correlated with the grade of the radical prostatectomy cancer (P ‫؍‬ .005). The cancers often lacked overt histologic features of malignancy. Benign prostatic acini were seen in five cases (14%), usually separate from the cancer. In 5 (33%) of the consultation cases, we would not have been able to diagnose cancer if not for the fact that atypical prostate glands should not be present after radical prostatectomy. In well-sampled radical prostatectomies, margins were almost always positive, as was extraprostatic extension. In cases with less sampling, there was a higher incidence of organ-confined disease and margin-negative disease implying suboptimal processing of the radical prostatectomy. After radical prostatectomy, recurrent cancer on needle biopsies may be focal and difficult to diagnose and must be assessed differently than in patients who have not had surgery.

show abstract

Influence of digital rectal massage on urinary prostate-specific antigen: Interest for the detection of local recurrence after radical prostatectomy

et al. 1998

View full text Add to dashboard Cite

BACKGROUND Following radical prostatectomy, urinary prostate‐specific antigen (uPSA) may originate from periurethral glands or from recurrent carcinomatous prostatic cells. We evaluated massage of the urethro‐vesical anastomosis as a uPSA‐releasing method for the detection of local recurrence. METHODS PSA was assessed (PSA IMx™, Abbott Diagnostic, Rungis, France) in serum and in the first voided urine before and after massage in 59 patients: 7 after cystoprostatectomy for bladder cancer, 22 with prostate in situ, and 30 after radical prostatectomy for prostate cancer. RESULTS No significant changes of uPSA were induced by the massage in cystoprostatectomy patients and in 4 radical prostatectomy patients with a negative biopsy of the anastomosis. In contrast, a significant increase of uPSA was observed after massage in the patients with prostate in situ and in 6 radical prostatectomy patients with biopsy‐proven local relapse. CONCLUSIONS uPSA before and after massage of the prostatic fossa may constitute a new and efficient tool for the detection of local recurrence, if these preliminary results are confirmed on a larger scale. Prostate 34:23–28, 1998. © 1998 Wiley‐Liss, Inc.

show abstract

The Value of Prostate Specific Antigen and Transrectal Ultrasound Guided Biopsy in Detecting Prostatic Fossa Recurrences Following Radical Prostatectomy

Cited by 106 publications

References 10 publications

Postradical prostatectomy TRUS-guided anastomotic biopsy. Where do we stand today?

Postradical prostatectomy TRUS-guided anastomotic biopsy. Where do we stand today?

Needle Biopsy of Recurrent Adenocarcinoma of the Prostate After Radical Prostatectomy

Influence of digital rectal massage on urinary prostate-specific antigen: Interest for the detection of local recurrence after radical prostatectomy

Contact Info

Product

Resources

About